Title: Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
Authors: Delmas, Pierre D ×
McClung, Michael R
Zanchetta, Jose R
Racewicz, Artur
Roux, Christian
Benhamou, Claude-Laurent
Mang, Zulema
Eusebio, Rachelle A
Beary, John F
Burgio, David E
Matzkin, Ellen
Boonen, Steven #
Issue Date: Jan-2008
Publisher: Elsevier science inc
Series Title: Bone vol:42 issue:1 pages:36-42
Abstract: Introduction: Risedronate has been shown to be effective in the treatment of postmenopausal osteoporosis when given orally in daily or weekly doses or on 2 consecutive days per month. This randomized, double-blind, multi-center study was designed to assess the efficacy and safety of a single 150 mg risedronate once-a-month oral dose compared with the 5 mg daily regimen.
ISSN: 8756-3282
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Gerontology and Geriatrics
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science